Fidelity Investments’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
Fidelity Investments's SION Position: Q3 2026 in Review
Fidelity Investments reduced its Sionna Therapeutics (SION) stake by 92% in Q3 2026, selling an estimated $5.9M and leaving 21,176 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #3974.
Fidelity Investments first reported a position in SION in Q3 2025 and has held it in 5 quarters since. The position peaked at $12.2M in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.
- Fidelity Investments held 21,176 shares of Sionna Therapeutics worth $111K as of Q3 2026.
- Fidelity Investments sold 257,116 Sionna Therapeutics shares in Q3 2026, an estimated $5.9M.
- Sionna Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3974 holding.
- Fidelity Investments first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 5 quarters since.
- Fidelity Investments's Sionna Therapeutics position peaked at $12.2M in Q2 2026.
- 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.